Applicant, as named in the Orange Book
Msd Sub Merck
Next listed expiry: Janumet Xr on 24 May 2027. 11 products with live protection, 1 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Janumet Xr NDA 202270 · 3 strengths metformin hydrochloride; sitagliptin phosphate | 24 May 2027 patent |
| Zolinza NDA 021991 vorinostat | 18 Mar 2028 patent, carve-out possible |
| Bridion NDA 022225 · 2 strengths sugammadex sodium | 12 Jun 2028 exclusivity |
| Janumet NDA 022044 · 2 strengths metformin hydrochloride; sitagliptin phosphate | 21 Jan 2029 patent |
| Isentress NDA 205786 raltegravir potassium | 11 Sep 2029 patent |
| Isentress NDA 203045 · 2 strengths raltegravir potassium | 11 Sep 2029 patent |
| Isentress NDA 022145 raltegravir potassium | 2 Jun 2030 patent |
| Segluromet NDA 209806 · 4 strengths ertugliflozin; metformin hydrochloride | 19 Dec 2031 patent |
| Steglatro NDA 209803 · 2 strengths ertugliflozin | 19 Dec 2031 patent |
| Steglujan NDA 209805 · 2 strengths ertugliflozin; sitagliptin phosphate | 19 Dec 2031 patent |
| Isentress Hd NDA 022145 raltegravir potassium | 30 Mar 2032 patent, carve-out possible |
Recent events
- Bridion · Generic approved · ANDA 215575, Qilu Pharm HainanApproved 28 Jul 2026Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 213915, MylanApproved 28 Jul 2026Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 214338, LupinApproved 28 Jul 2026Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 214319, Sun Pharm Inds IncApproved 28 Jul 2026Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 214311, SandozApproved 28 Jul 2026Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 214306, ZenaraApproved 28 Jul 2026Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 219448, Fresenius Kabi UsaApproved 28 Jul 2026Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 214236, Dr ReddysApproved 28 Jul 2026Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 214230, Mankind PharmaApproved 28 Jul 2026Detected 25 Oct 2026
- Janumet · Generic approved · ANDA 202426, ApotexApproved 30 Apr 2026Detected 25 Oct 2026
- Janumet · Generic tentatively approved · ANDA 208535, Zydus Pharms Usa IncTentative approval 30 Jun 2026Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 218814, SteriscienceApproved 28 Jul 2026Detected 25 Oct 2026
- Janumet · First generic approved · ANDA 202388, SandozApproved 2 Dec 2025Detected 25 Oct 2026
- Janumet · Generic approved · ANDA 202388, SandozApproved 2 Dec 2025Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 214126, Teva Pharms Usa IncApproved 28 Jul 2026Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 218727, HikmaApproved 28 Jul 2026Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 218728, HikmaApproved 28 Jul 2026Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 215701, ShandongApproved 6 Oct 2026Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 215260, TamarangApproved 28 Jul 2026Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 214368, MsnApproved 28 Jul 2026Detected 25 Oct 2026
- Bridion · Generic approved · ANDA 214364, GlandApproved 28 Jul 2026Detected 25 Oct 2026
- Janumet Xr · Enters 12-month window basis: patentListed date 24 May 2027Detected 24 Oct 2026
- Janumet Xr · Enters 12-month window basis: patentListed date 24 May 2027Detected 24 Oct 2026
- Janumet Xr · Enters 12-month window basis: patentListed date 24 May 2027Detected 24 Oct 2026
Products without listed protection (1)
| Drug | Earliest generic entry |
|---|---|
| Invanz NDA 021337 ertapenem sodium | open now no listed protection |